Empowered Funds
STIM icon

Empowered Funds’s Neuronetics STIM Stock Holding History

Empowered Funds’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$211K Buy
+90,305
New +$222K ﹤0.01% 2216

Other funds holding STIM

Madryn Asset Management
Madryn Asset Management New York $55.5M AUM 7.4% 1-Year Est. Return
Wexford Capital
Wexford Capital West Palm Beach, Florida $763M AUM 59.25% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Lane Generational
Lane Generational Dover, Massachusetts $111M AUM 16.63% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
AdvisorShares Investments
AdvisorShares Investments Bethesda, Maryland $796M AUM 17.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Empowered Funds's STIM Position: Q3 2026 in Review

Empowered Funds opened a new position in Neuronetics (STIM) in Q3 2026: 90,305 shares worth $211K. The stake represents ﹤0.01% of the portfolio and ranks #2216 among its holdings.

58 funds tracked by Wall St. Rank hold STIM as of Q3 2026.

  • Empowered Funds held 90,305 shares of Neuronetics worth $211K as of Q3 2026.
  • Neuronetics was a new Empowered Funds position in Q3 2026.
  • Neuronetics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2216 holding.
  • 58 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.